Clinical Trials
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
- A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
- Sirolimus for Cowden Syndrome With Colon Polyposis
- 1.5T Intraoperative MR Imaging in Craniopharyngiomas
- A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury
- Craniopharyngioma With Tumoral Hemorrhage
- Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients
- Intranasal Oxytocin in Hypothalamic Obesity
- Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)
- Neuromodulation for Hypothalamic Obesity
- Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
- Prospective Study of Children and Adolescents With Craniopharyngioma
- Sleep Wake and Melatonin Pattern in Craniopharyngioma
- Weight Gain in Surgically Treated Adult-onset Craniopharyngioma
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
- 1.5T Intraoperative MR Imaging in Craniopharyngiomas
- A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury
- Craniopharyngioma With Tumoral Hemorrhage
- Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients
- Intranasal Oxytocin in Hypothalamic Obesity
- Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)
- Neuromodulation for Hypothalamic Obesity
- Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
- Prospective Study of Children and Adolescents With Craniopharyngioma
- Sleep Wake and Melatonin Pattern in Craniopharyngioma
- Weight Gain in Surgically Treated Adult-onset Craniopharyngioma
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
- A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
- A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections
- Clinical Trial of Pulmonary Cryptococcosis in China
- Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules
- Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
- Inpatient Package to Reduce HIV and AIDS-related Death in Zambia
- Operational Research for Cryptococcal Antigen Screening
- Vicente Ferrer HIV Cohort Study
- A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS
- A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3
- A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
- A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients
- A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
- A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
- A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea
- A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
- Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs
- Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
- Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
- Cryptosporidiosis and Enteropathogens in Bangladesh
- Cryptosporidium Species in Sohag Governorate
- Field Studies of Amebiasis in Bangladesh
- Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients
- Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children
- Open-Label “Compassionate” Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients
- Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)
- Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
- The Effectiveness of Cow’s Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea
- Transmission and the Respiratory Tract in Cryptosporidiosis
- Treatment of Chronic Cryptosporidiosis in AIDS Patients
- Treatment of Cryptosporidiosis
- Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
- A PHASE 1, DOSE ESCALATION STUDY OF CDK-003 (exoIL-12) IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL)
- A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
- A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
- A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors
- ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells
- Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution
- Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas
- MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
- Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum
- A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
- CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
- Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors
- Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
- Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
- Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
- Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors
- 131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma
- 9-ING-41 in Pediatric Patients With Refractory Malignancies.
- A Phase 1/2 Study of SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
- A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
- A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors or DIPG
- A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)
- A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
- A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)
- A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
- A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
- A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma and H3 K27M-Mutant High-Grade Glioma
- Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma
- Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
- Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
- C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas
- CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG)
- Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma
- Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
- Combination Therapy for the Treatment of Diffuse Midline Gliomas
- Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered
- FUS Etoposide for DMG – A Feasibility Study
- Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
- Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
- HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
- Hypofractionated Radiotherapy for Recurrent DIPG
- Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
- International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
- Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).
- Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
- Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
- Molecular Profiling for Individualized Treatment Plan for DIPG
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
- MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
- Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma
- Nimotuzumab in Children With Intrinsic Pontine Glioma
- Nimotuzumab in Combined With Concurrent Radiochemotherapy in the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Children
- Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)
- ONC201 in Pediatric H3 K27M Gliomas
- Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
- Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
- PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma
- Precision Medicine and Adoptive Cellular Therapy
- Re-Irradiation of Progressive or Recurrent DIPG
- REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
- rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines
- Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors
- Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses
- Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
- Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
- 18F-deoxyglucose (FDG) PET-CMD
- A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
- A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy
- A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy
- A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure
- A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy
- A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure
- A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491
- A Study of Impact of Anemia on Morbidity and Mortality in Children With Dilated Cardiomyopathy
- A Trial of Autologous Bone Marrow Derived Stem Cells in Paediatric Heart Failure
- ACC – Atrial Contribution to CRT
- An Integrative-“Omics” Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
- An Open Label Rollover Trial for Patients Randomized to the Control Group of Study LSH-10-001
- Arrhythmia Prediction Trial
- Assessment of Right Ventricular Function in Advanced Heart Failure
- Association of Obesity and Cardiovascular Outcomes in Dilated Cardiomyopathy
- Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy
- Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy
- BiPAP for Cardiomyopathy With Central Sleep Apnea
- Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
- Brain Function and Perfusion in Patients With Heart Failure
- Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)
- Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy
- Cell Therapy In Dilated Cardiomyopathy
- Clinical and Genetic Examinations of Dilated Cardiomyopathy
- Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
- Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
- Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe
- Continues Positive Airway Pressure Treatment for Patients With Dilated Cardiomyopathy and Obstructive Sleep Apnea
- CorCinch-HF Repair System in Patients Who Present With Symptomatic Non-Ischemic or Ischemic Dilated Cardiomyopathy
- Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
- Danish ICD Study in Patients With Dilated Cardiomyopathy
- DCM Precision Medicine Study
- Defining the Role of Insulin Resistance in ‘Idiopathic’ Dilated Cardiomyopathy
- Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study
- Early Administration of Ivabradine in Children With Heart Failure
- Echo Assessment of Intraventricular Dyssynchrony
- Effect of Aldosterone on Energy Starvation in Heart Failure
- Effect of Allopurinol on Left Ventricular Function in Children With Dilated Cardiomyopathy
- Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
- Effect of Rosuvastatin on Left Ventricular Remodeling
- Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
- Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality
- Evaluation of the CIRCULATE Catheter for Transcoronary Administration of Pharmacologic and Cell-based Agents
- Examining the Effects of Mitochondrial Oxidative Stress in DCM
- Exercise Stress MRI to Evaluate Aortic Function (Compliance, Distensibility, Pulse Wave Velocity) and Left Ventricular Function : Validation in Healthy Volunteers and in Selected Patients. A Pilot Study.
- Exome Sequencing Study in Cardiomyopathy to Identify New Risk Variants
- Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
- Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
- German Centre for Cardiovascular Research Cardiomyopathy Register
- Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
- Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO
- Honey in Idiopathic Dilated Cardiomyopathy
- Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
- Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
- Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy
- Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy
- Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
- Intraventricular Stasis In Cardiovascular Disease
- Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy
- Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study
- Long-term Evaluation of Patients Receiving Bone Marrow-derived Cell Administration for Heart Disease
- Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium
- Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
- Metabolic Characterization of Patients With Dilated Cardiomyopathy
- Metabolomic Study of All-age Cardiomyopathy
- Metabolomics and Microbiomics in Cardiovascular Diseases Mannheim
- Molecular and Imaging Studies of Cardiovascular Health and Disease
- Multicenter Exploratory Study of Accelerometry in Dilated Cardiomyopathy
- Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
- Myocardial Metabolism in Patients With Dilated Cardiomyopathy
- Nesiritide – Dilated Cardiomyopathy
- Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie)
- Observational Trial of Cardiotoxicity in Patients Undergoing Chemotherapy.
- Optimized Biventricular Pacing Allograft Recipients
- Optimizing Left Ventricular Lead To Improve Cardiac Output
- Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
- Pathophysiology of Dilated Cardiomyopathy
- Pediatric Cardiomyopathy Mutation Analysis
- Potential Role of Water-soluble Ubiquinol in Complementary Therapy for Pediatric Dilated Cardiomyopathy
- Prospective Study Looking at Quality of Life Measures in Non-ischaemic Cardiomyopathy After Mitral Valve Repair
- PUFAs and Left Ventricular Function in Heart Failure
- Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy
- Randomized Trial of Interventions to Improve Warfarin Adherence
- Relationship Between Abnormalities of Desmin Cytoskeleton, Mitochondrial Activity and Expression of Ubiquitin in Aspect of Pathogenesis of Heart Failure and Prognosis
- Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy (REMEDIUM)
- Respiratory Muscles Training in Patients With Dilated Cardiomyopathy
- Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to Bedside
- Resynchronization Therapy in Young Patients With and Without CHD
- Reverse Remodelling and Remission Markers in the Serial Evaluation of Recent-onset Dilated Cardiomyopathy
- Risk Stratification in Children and Adolescents With Primary Cardiomyopathy
- Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)
- Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy
- Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
- Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery
- Simvastatin Therapy in Patients With Dilated Cardiomyopathy.
- Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
- Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy
- Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
- Testing Strategies to Improving Warfarin Adherence
- The Arrhythmogenic Potential of Midwall Septal Fibrosis in Dilated Cardiomyopathy
- The Cardiovascular Genetic and Therapeutic Implications of Muscular Dystrophy
- The Genetics of Cardiomyopathy and Heart Failure
- The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study
- The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle
- Therapy With Verapamil or Carvedilol in Chronic Heart Failure
- TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
- Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure
- Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy
- Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
- Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM
- Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
- Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
- Using Ripple Mapping to Guide Substrate Ablation of Scar Related Ventricular Tachycardia.
- Withdrawal of Medication in Recovered DCM